Results 91 to 100 of about 13,152 (241)

AIDS-Related Mycoses: Current Progress in the Field and Future Priorities. [PDF]

open access: yes, 2017
Opportunistic fungal infections continue to take an unacceptably heavy toll on the most disadvantaged living with HIV-AIDS, and are a major driver for HIV-related deaths. At the second EMBO Workshop on AIDS-Related Mycoses, clinicians and scientists from
Armstrong-James, D   +6 more
core   +2 more sources

Opportunities and Challenges of Population Pharmacogenomics

open access: yesAnnals of Human Genetics, Volume 89, Issue 5, Page 384-397, September 2025.
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou   +3 more
wiley   +1 more source

Cryptococcus gattii Meningoencephalitis in an Immunocompetent Person 13 Months after Exposure [PDF]

open access: yes, 2018
: A 53-year old immunocompetent Swiss female is described who developed severe meningoencephalitis due to infection with Cryptococcus gattii 13 months following exposure on Vancouver Island, Canada.
Bosshard, P.   +6 more
core  

Cryptococcal choroiditis in advanced AIDS with clinicopathologic correlation. [PDF]

open access: yes, 2018
PurposeTo describe a case of disseminated cryptococcal meningitis with multifocal choroiditis and provide optical coherence tomography (OCT) findings correlated with described histopathology in a patient with advanced acquired immunodeficiency syndrome ...
Aderman, Christopher M   +5 more
core   +2 more sources

Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China

open access: yesBrazilian Journal of Infectious Diseases
Cryptococcus spp. are common causes of mycoses in immunocompromised patients. To determine the drug susceptibilities of clinical Cryptococcus spp. isolates, the characteristics of 61 clinical Cryptococcus spp.
Meng Li   +4 more
doaj   +1 more source

Vertebral infection with Candida albicans failing caspofungin and fluconazole combination therapy but successfully treated with high dose liposomal amphotericin B and flucytosine

open access: yesMedical Mycology Case Reports, 2014
A patient with Candida spondylitis failed two weeks of fluconazole combined with caspofungin, and the infection relapsed despite six weeks of liposomal amphotericin B followed by two months of fluconazole.
Line Storm   +4 more
doaj   +1 more source

The dual role of Candida glabrata Drug:H+ Antiporter CgAqr1 (ORF CAGL0J09944g) in antifungal drug and acetic acid resistance

open access: yesFrontiers in Microbiology, 2013
Opportunistic Candida species often have to cope with inhibitory concentrations of acetic acid, in the acidic environment of the vaginal mucosa. Given that the ability of these yeast species to tolerate stress induced by weak acids and antifungal drugs ...
Catarina eCosta   +9 more
doaj   +1 more source

Aspergillosis of the CNS in a pediatric liver transplant recipient: Case report and review [PDF]

open access: yes, 1991
A 2-month-old infant who had undergone orthotopic liver transplantation at the age of 2 weeks for carbamoyl phosphate synthetase deficiency developed infection of the CNS due to Aspergillus fumigatus.
Green, M   +4 more
core   +1 more source

Antifungal Susceptibilities of Cryptococcus neoformans

open access: yesEmerging Infectious Diseases, 2004
Susceptibility profiles of medically important fungi in less-developed countries remain uncharacterized. We measured the MICs of amphotericin B, 5-flucytosine, fluconazole, itraconazole, and ketoconazole for Cryptococcus neoformans clinical isolates from
Lennox K. Archibald   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy